Johnson & Johnson (JNJ) Stock Forecast, Price Target & Predictions
JNJ Stock Forecast
Johnson & Johnson stock forecast is as follows: an average price target of $179.13 (represents a 16.32% upside from JNJ’s last price of $154.00) and a rating consensus of 'Buy', based on 21 wall street analysts offering a 1-year stock forecast.
JNJ Price Target
The average price target for Johnson & Johnson (JNJ) is $179.13 based on 1-year price targets from 21 Wall Street analysts in the past 3 months, with a price target range of $215.00 to $150.00. This represents a potential 16.32% upside from JNJ's last price of $154.00.
JNJ Analyst Ratings
According to 21 Wall Street analysts, Johnson & Johnson's rating consensus is 'Buy'. The analyst rating breakdown for JNJ stock is 0 'Strong Buy' (0.00%), 11 'Buy' (52.38%), 10 'Hold' (47.62%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Johnson & Johnson Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 16, 2024 | Chris Shibutani | Goldman Sachs | $159.00 | $164.28 | -3.21% | 3.25% |
| Oct 16, 2024 | Terence Flynn | Morgan Stanley | $175.00 | $164.10 | 6.64% | 13.64% |
| Oct 16, 2024 | Shagun Singh | RBC Capital | $181.00 | $164.10 | 10.30% | 17.53% |
| Oct 16, 2024 | Joanne Wuensch | Citigroup | $185.00 | $164.10 | 12.74% | 20.13% |
| Oct 15, 2024 | Larry Biegelsen | Wells Fargo | $166.00 | $164.10 | 1.16% | 7.79% |
| Oct 15, 2024 | Rick Wise | Stifel Nicolaus | $170.00 | $164.10 | 3.60% | 10.39% |
| Oct 15, 2024 | Joanna Wuensch | Citigroup | $180.00 | $163.77 | 9.91% | 16.88% |
| Oct 14, 2024 | Louise Chen | Cantor Fitzgerald | $215.00 | $161.60 | 33.04% | 39.61% |
| Jul 23, 2024 | Narumi Nakagiri | Johnson Rice | $150.00 | $154.24 | -2.75% | -2.60% |
| Jul 17, 2024 | Rick Wise | Stifel Nicolaus | $160.00 | $157.16 | 1.81% | 3.90% |
The latest Johnson & Johnson stock forecast, released on Oct 16, 2024 by Chris Shibutani from Goldman Sachs, set a price target of $159.00, which represents a -3.21% decrease from the stock price at the time of the forecast ($164.28), and a 3.25% increase from JNJ last price ($154.00).
Johnson & Johnson Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 8 | 21 |
| Avg Price Target | - | $178.88 | $170.14 |
| Last Closing Price | $154.00 | $154.00 | $154.00 |
| Upside/Downside | -100.00% | 16.16% | 10.48% |
In the current month, the average price target of Johnson & Johnson stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Johnson & Johnson's last price of $154.00. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 16, 2024 | Bank of America Securities | Neutral | Neutral | Hold |
| Oct 15, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| Oct 15, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Oct 15, 2024 | Citigroup | Buy | Buy | Hold |
| Oct 14, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Oct 14, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
| Oct 14, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Oct 14, 2024 | BMO Capital | Market Perform | Market Perform | Hold |
| Oct 14, 2024 | Johnson Rice | Neutral | Neutral | Hold |
| Oct 10, 2024 | RBC Capital | Buy | Buy | Hold |
Johnson & Johnson's last stock rating was published by Bank of America Securities on Oct 16, 2024. The company gave JNJ a "Neutral" rating, the same as its previous rate.
Johnson & Johnson Financial Forecast
Johnson & Johnson Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $23.71B | $21.35B | $25.53B | $24.75B | $24.80B | $23.79B | $24.02B | $23.43B | $22.48B | $23.34B | $23.31B | $22.32B | - | $21.08B | $18.34B | $20.69B | $20.75B | $20.73B |
| Avg Forecast | $24.92B | $24.29B | $24.21B | $23.20B | $23.24B | $23.19B | $22.93B | $22.04B | $22.46B | $22.17B | $22.33B | $21.40B | $21.02B | $21.04B | $24.63B | $23.60B | $23.88B | $23.36B | $23.77B | $23.62B | $25.28B | $23.64B | $22.49B | $21.98B | $21.66B | $20.20B | $17.61B | $19.73B | $20.80B | $20.08B |
| High Forecast | $25.26B | $24.61B | $24.53B | $23.51B | $23.55B | $23.51B | $23.24B | $22.13B | $22.91B | $22.19B | $22.33B | $21.41B | $21.06B | $21.32B | $24.97B | $23.92B | $24.20B | $23.66B | $24.07B | $23.93B | $25.60B | $23.94B | $22.78B | $22.26B | $21.94B | $20.46B | $17.83B | $19.98B | $21.06B | $20.34B |
| Low Forecast | $24.71B | $24.08B | $24.00B | $23.00B | $23.04B | $22.99B | $22.74B | $21.96B | $22.22B | $22.15B | $22.33B | $21.40B | $21.01B | $20.86B | $24.42B | $23.40B | $23.68B | $23.10B | $23.51B | $23.36B | $24.99B | $23.38B | $22.24B | $21.74B | $21.42B | $19.97B | $17.41B | $19.51B | $20.57B | $19.86B |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 11 | 5 | 4 | 4 | 8 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 14 | 9 | 9 | 15 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | 1.01% | 1.04% | 1.05% | 1.04% | 1.02% | 1.01% | 0.99% | 0.89% | 0.99% | 1.04% | 1.02% | - | 1.04% | 1.04% | 1.05% | 1.00% | 1.03% |
Johnson & Johnson's average Quarter revenue forecast for Mar 24 based on 4 analysts is $21.40B, with a low forecast of $21.40B, and a high forecast of $21.41B. JNJ's average Quarter revenue forecast represents a -9.72% decrease compared to the company's last Quarter revenue of $23.71B (Dec 23).
Johnson & Johnson EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 11 | 5 | 4 | 4 | 8 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 14 | 9 | 9 | 15 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $5.50B | $6.26B | $6.97B | $6.73B | $6.74B | $6.38B | $6.26B | $7.11B | $3.67B | $5.68B | $8.54B | $9.39B | - | $6.26B | $5.71B | $8.58B | $6.12B | $3.42B |
| Avg Forecast | $8.42B | $8.20B | $8.17B | $7.83B | $7.85B | $7.83B | $7.74B | $7.44B | $7.59B | $7.49B | $7.54B | $10.68B | $7.10B | $7.10B | $8.32B | $9.71B | $8.10B | $7.81B | $7.95B | $8.83B | $8.46B | $7.91B | $7.52B | $8.02B | $7.25B | $6.76B | $5.89B | $7.29B | $6.96B | $6.72B |
| High Forecast | $8.53B | $8.31B | $8.28B | $7.94B | $7.95B | $7.94B | $7.85B | $7.47B | $7.74B | $7.49B | $7.54B | $12.81B | $7.11B | $7.20B | $8.43B | $11.65B | $9.72B | $7.91B | $8.05B | $10.59B | $8.56B | $8.01B | $7.62B | $9.63B | $7.34B | $6.84B | $5.97B | $8.75B | $7.05B | $6.80B |
| Low Forecast | $8.34B | $8.13B | $8.10B | $7.77B | $7.78B | $7.77B | $7.68B | $7.42B | $7.50B | $7.48B | $7.54B | $8.54B | $7.10B | $7.04B | $8.25B | $7.77B | $6.48B | $7.73B | $7.86B | $7.06B | $8.36B | $7.82B | $7.44B | $6.42B | $7.17B | $6.68B | $5.82B | $5.84B | $6.88B | $6.64B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.77% | 0.88% | 0.84% | 0.69% | 0.83% | 0.82% | 0.79% | 0.81% | 0.43% | 0.72% | 1.14% | 1.17% | - | 0.93% | 0.97% | 1.18% | 0.88% | 0.51% |
4 analysts predict JNJ's average Quarter EBITDA for Mar 24 to be $10.68B, with a high of $12.81B and a low of $8.54B. This is 94.20% upper than Johnson & Johnson's previous annual EBITDA (Dec 23) of $5.50B.
Johnson & Johnson Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 11 | 5 | 4 | 4 | 8 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 14 | 9 | 9 | 15 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $3.52B | $26.03B | $5.14B | $-68.00M | $4.74B | $4.46B | $4.81B | $5.15B | $1.74B | $3.67B | $6.28B | $6.20B | - | $3.55B | $3.63B | $5.80B | $4.01B | $1.75B |
| Avg Forecast | $6.81B | $6.42B | $6.85B | $6.53B | $6.11B | $6.52B | $6.59B | $6.46B | $4.90B | $5.36B | $6.58B | $7.21B | $5.54B | $6.11B | $6.35B | $6.56B | $5.31B | $6.01B | $6.16B | $5.96B | $5.14B | $5.71B | $5.56B | $5.42B | $4.42B | $4.80B | $3.63B | $4.93B | $4.54B | $4.88B |
| High Forecast | $6.93B | $6.53B | $6.97B | $6.64B | $6.22B | $6.63B | $6.71B | $6.53B | $5.17B | $5.39B | $6.58B | $8.66B | $5.61B | $6.22B | $6.46B | $7.87B | $6.37B | $6.11B | $6.26B | $7.15B | $5.22B | $5.80B | $5.65B | $6.50B | $4.50B | $4.88B | $3.69B | $5.91B | $4.61B | $4.96B |
| Low Forecast | $6.74B | $6.35B | $6.78B | $6.46B | $6.05B | $6.45B | $6.52B | $6.36B | $4.78B | $5.32B | $6.58B | $5.77B | $5.49B | $6.04B | $6.28B | $5.25B | $4.25B | $5.93B | $6.07B | $4.77B | $5.06B | $5.63B | $5.48B | $4.34B | $4.36B | $4.73B | $3.58B | $3.94B | $4.47B | $4.81B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.64% | 4.26% | 0.81% | -0.01% | 0.89% | 0.74% | 0.78% | 0.86% | 0.34% | 0.64% | 1.13% | 1.14% | - | 0.74% | 1.00% | 1.18% | 0.88% | 0.36% |
Johnson & Johnson's average Quarter net income forecast for Mar 24 is $7.21B, with a range of $5.77B to $8.66B. JNJ's average Quarter net income forecast represents a 104.92% increase compared to the company's last Quarter net income of $3.52B (Dec 23).
Johnson & Johnson SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 11 | 5 | 4 | 4 | 8 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 14 | 9 | 9 | 15 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $6.51B | $5.40B | $6.67B | $6.14B | $7.15B | $6.09B | $6.23B | $5.94B | $6.46B | $6.00B | $6.07B | $5.43B | - | $5.43B | $4.99B | $5.20B | $6.04B | $5.37B |
| Avg Forecast | $6.32B | $6.16B | $6.14B | $5.88B | $5.89B | $5.88B | $5.81B | $5.59B | $5.69B | $5.62B | $5.66B | $6.48B | $5.33B | $5.33B | $6.24B | $5.89B | $7.99B | $5.92B | $6.03B | $5.35B | $6.41B | $5.99B | $5.70B | $4.86B | $5.49B | $5.12B | $4.46B | $4.42B | $5.27B | $5.09B |
| High Forecast | $6.40B | $6.24B | $6.22B | $5.96B | $5.97B | $5.96B | $5.89B | $5.61B | $5.81B | $5.63B | $5.66B | $7.77B | $5.34B | $5.40B | $6.33B | $7.06B | $9.59B | $6.00B | $6.10B | $6.42B | $6.49B | $6.07B | $5.77B | $5.84B | $5.56B | $5.19B | $4.52B | $5.31B | $5.34B | $5.16B |
| Low Forecast | $6.26B | $6.10B | $6.08B | $5.83B | $5.84B | $5.83B | $5.76B | $5.57B | $5.63B | $5.62B | $5.66B | $5.18B | $5.33B | $5.29B | $6.19B | $4.71B | $6.40B | $5.85B | $5.96B | $4.28B | $6.34B | $5.93B | $5.64B | $3.89B | $5.43B | $5.06B | $4.41B | $3.54B | $5.21B | $5.03B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.22% | 1.01% | 1.07% | 1.04% | 0.89% | 1.03% | 1.03% | 1.11% | 1.01% | 1.00% | 1.07% | 1.12% | - | 1.06% | 1.12% | 1.18% | 1.15% | 1.06% |
Johnson & Johnson's average Quarter SG&A projection for Mar 24 is $6.48B, based on 4 Wall Street analysts, with a range of $5.18B to $7.77B. The forecast indicates a -0.57% fall compared to JNJ last annual SG&A of $6.51B (Dec 23).
Johnson & Johnson EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 11 | 5 | 4 | 4 | 8 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 14 | 9 | 9 | 15 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $1.35 | $10.81 | $1.98 | $-0.03 | $1.80 | $1.70 | $1.83 | $1.96 | $0.66 | $1.39 | $2.38 | $2.35 | - | $1.35 | $1.38 | $2.20 | $1.52 | $0.67 |
| Avg Forecast | $2.81 | $2.64 | $2.82 | $2.69 | $2.52 | $2.68 | $2.72 | $2.66 | $2.02 | $2.21 | $2.71 | $2.66 | $2.28 | $2.52 | $2.62 | $2.50 | $2.24 | $2.48 | $2.54 | $2.59 | $2.12 | $2.35 | $2.29 | $2.34 | $1.82 | $1.98 | $1.49 | $2.02 | $1.87 | $2.01 |
| High Forecast | $2.85 | $2.69 | $2.87 | $2.74 | $2.56 | $2.73 | $2.76 | $2.69 | $2.13 | $2.22 | $2.71 | $2.66 | $2.31 | $2.56 | $2.66 | $2.55 | $2.28 | $2.52 | $2.58 | $2.63 | $2.15 | $2.39 | $2.33 | $2.38 | $1.85 | $2.01 | $1.52 | $2.05 | $1.90 | $2.04 |
| Low Forecast | $2.77 | $2.61 | $2.79 | $2.66 | $2.49 | $2.66 | $2.69 | $2.62 | $1.97 | $2.19 | $2.71 | $2.65 | $2.26 | $2.49 | $2.59 | $2.47 | $2.21 | $2.44 | $2.50 | $2.55 | $2.09 | $2.32 | $2.26 | $2.30 | $1.79 | $1.95 | $1.47 | $1.99 | $1.84 | $1.98 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.59% | 4.30% | 0.76% | -0.01% | 0.80% | 0.69% | 0.72% | 0.76% | 0.31% | 0.59% | 1.04% | 1.01% | - | 0.68% | 0.92% | 1.09% | 0.82% | 0.33% |
According to 4 Wall Street analysts, Johnson & Johnson's projected average Quarter EPS for Mar 24 is $2.66, with a low estimate of $2.65 and a high estimate of $2.66. This represents a 96.72% increase compared to JNJ previous annual EPS of $1.35 (Dec 23).
Johnson & Johnson Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| PFE | Pfizer | $24.80 | $44.76 | 80.48% | Hold |
| MRK | Merck | $96.31 | $128.89 | 33.83% | Buy |
| BMY | Bristol-Myers Squibb Company | $56.22 | $65.50 | 16.51% | Hold |
| JNJ | Johnson & Johnson | $154.00 | $179.13 | 16.32% | Buy |
| AMGN | Amgen | $283.61 | $301.81 | 6.42% | Buy |
| ABBV | AbbVie | $164.99 | $173.30 | 5.04% | Buy |
| LLY | Eli Lilly and Company | $746.20 | $778.10 | 4.27% | Buy |
| GILD | Gilead Sciences | $88.40 | $81.77 | -7.50% | Buy |